Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Magnetic resonance imaging in cardiac amyloidosis.

× No keyword cloud information.

8 in total

1. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.

Authors: Rodney H Falk; Sharmila Dorbala
Journal: Eur J Nucl Med Mol Imaging Date: 2011-03 Impact factor: 9.236

2. Cardiac MOLLI T₁ mapping at 3.0 T: comparison of patient-adaptive dual-source RF and conventional RF transmission.

Authors: Michael Rasper; Jonathan Nadjiri; Alexandra S Sträter; Marcus Settles; Karl-Ludwig Laugwitz; Ernst J Rummeny; Armin M Huber
Journal: Int J Cardiovasc Imaging Date: 2017-01-30 Impact factor: 2.357

Review 3. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors: Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal: J Nucl Cardiol Date: 2014-04 Impact factor: 5.952

4. Cardiac Amyloidosis Diagnosis with Magnetic Resonance Imaging: A Case Report.

Authors: Meidi El Issa; Malik El Issa; Besma Sidia
Journal: Cureus Date: 2018-03-15

Review 5. Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis.

Authors: Sajan S Gill; Eric Fellin; Lisa Stampke; Yunazi Zhao; Ahmad Masri
Journal: Methodist Debakey Cardiovasc J Date: 2022-03-14

6. Left ventricular active strain energy density is a promising new measure of systolic function.

Authors: David H MacIver; Peter Agger; Jonathan C L Rodrigues; Henggui Zhang
Journal: Sci Rep Date: 2022-07-26 Impact factor: 4.996

7. Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study.

Authors: Rui Xia; Fabao Gao; Jiayu Sun; Chunchao Xia; Zhangxue Hu; Yingkun Guo
Journal: Pak J Med Sci Date: 2013-11 Impact factor: 1.088

8. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.

Authors: Grigorios Chatzantonis; Michael Bietenbeck; Anca Florian; Claudia Meier; Philipp Stalling; Dennis Korthals; Holger Reinecke; Ali Yilmaz
Journal: Clin Res Cardiol Date: 2020-05-05 Impact factor: 5.460